Nektar Therapeutics
NKTR’s short interest surges to 1.82 million shares
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
Analyzing Nektar Therapeutics (NKTR) After Recent Trading Activity
In a filing, Nektar Therapeutics revealed its Chief R&D Officer Zalevsky Jonathan unloaded Company’s shares for reported $62802.0 on Nov ...
H.C. Wainwright reiterates Nektar Therapeutics (NKTR) stock to a Buy
Nektar Therapeutics’s filing revealed that its Chief R&D Officer Zalevsky Jonathan unloaded Company’s shares for reported $62802.0 on Nov 25 ...
Nektar Therapeutics’s latest rating changes from various analysts
Nektar Therapeutics’s filing revealed that its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $0.31 million on ...
Nektar Therapeutics (NKTR) receives a Buy rating from H.C. Wainwright
Nektar Therapeutics’s filing revealed that its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $0.31 million on ...
Investing in Nektar Therapeutics (NKTR) Is Getting More Attractive
In a filing, Nektar Therapeutics revealed its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $0.31 million ...
NKTR (Nektar Therapeutics) may reap gains as insiders became active recently
In a filing, Nektar Therapeutics revealed its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $0.31 million ...
